Action JPH JERUSALEM PHARMACEUTICALS CO. LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jerusalem Pharmaceuticals Co. Ltd.

Actions

JPH

PS2016112695

Cours en clôture Palestine Exchange
Autres places de cotation
 00:00:00 25/04/2024 		Varia. 5j. Varia. 1 janv.
3,81 USD -.--% Graphique intraday de Jerusalem Pharmaceuticals Co. Ltd. -.--% +0,26%
2023 Jerusalem Pharmaceuticals Co. Ltd. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI
2023 Jerusalem Pharmaceuticals Co. Ltd. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019
Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 June 2019
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Unaudited Earnings Results for the Year Ended December 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Earnings Results for the Nine Months Ended September 30, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Earnings Results for the First Half of 2018
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Earnings Results for the Full Year Ended December 31, 2017
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action JPH
  4. Actualités Jerusalem Pharmaceuticals Co. Ltd.
  5. Autres langues